List of Oncology Medication For

Solid Tumors

Treatment for solid tumors depends on several factors, including the type and stage of the tumor, its location, and the patient’s overall health. Treatment options may include surgery to remove the tumor, chemotherapy, radiation therapy, targeted therapy, immunotherapy, or a combination of these approaches.

Libtayo (cemiplimab)

Skin

Libtayo (cemiplimab)

Libtayo is used to treat certain types of basal cell carcinoma and cutaneous squamous cell carcinoma (types of skin cancer) that are locally advanced or have spread to other parts of the body.

Brand Name:	Libtayo
Generic Name:	cemiplimab
Strength:
Manufacturer:
Approved By:	EMA, USFDA

Source Details: Patient Information

IPN, New Delhi can facilitate patient to import of “Libtayo (cemiplimab)” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for Libtayo (cemiplimab) price list or cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.

LITFULO (ritlecitinib) capsules

Skin

LITFULO (ritlecitinib) capsules, for oral use Initial U.S. Approval: 2023

Litfulo (ritlecitinib) is a prescription oral capsule used to treat severe alopecia in adults and certain teenagers

Brand Name:	LITFULO
Generic Name:	ritlecitinib
Strength:	Capsules: 50 mg of ritlecitinib
Manufacturer:	Pfizer Inc.
Approved By:	EMA, USFDA

Source Details: Patient Information

IPN, New Delhi can facilitate patient to import of “LITFULO (ritlecitinib) capsules” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for LITFULO (ritlecitinib) capsules price list or cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.

Indian Pharma Network (IPN) serves as a legitimate consultant and facilitator situated in New Delhi, India. With over two decades of industry experience, IPN offers extensive coverage across India, including prominent cities such as Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik, and various other regions in India.

loncastuximab tesirine-lpyl for injection

Lymphoma

loncastuximab tesirine-lpyl for injection
for intravenous use Initial U.S. Approval: 2021

Zynlonta (loncastuximab tesirine-lpyl) is a prescription medicine used to treat adults with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) after at least 2 prior systemic therapies.

Facts about loncastuximab tesirine-lpyl for injection

Disease Indications-Lymphoma
Manufacturer-ADC Therapeutics
Usage-Intravenous
Medicine Approved By-Food and Drug Administration (FDA)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “loncastuximab tesirine-lpyl for injection” based on the information you provide.

Lorviqua Tablets

Lung Cancer

Lorviqua 25 mg film-coated tablets

Lorviqua (lorlatinib) is a medicine indicated for the treatment of previously treated patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC). The medicine is marketed in the USA under the brand name Lorbrena, and in the EU under the brand name Lorviqua. We can help you obtain Lorviqua (lorlatinib) on our website.

Facts about Lorviqua tablets

Disease Indications-Lung Cancer
Manufacturer-Pfizer Limited
Usage-Oral
Medicine Approved By-European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “Lorviqua tablets” based on the information you provide.

Lurbinectedin-Solution

Lung Cancer

Zepzelca 4 Mg Intravenous Solution
Alkylating Agents

Zepzelca (lurbinectedin) is a medication used for the treatment of adult patients with metastatic small cell lung cancer (SCLC) with disease progression on or after platinum-based chemotherapy.

Facts about Lurbinectedin-solution

Disease Indications-Lung Cancer
Manufacturer-Jazz Pharmaceuticals
Usage-Intravenous
Medicine Approved By-Food and Drug Administration (FDA)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “Lurbinectedin-solution” based on the information you provide.

luspatercept-aamt for injection

Lymphoma

luspatercept-aamt for injection
for subcutaneous use Initial U.S. Approval: 2019

Reblozyl (luspatercept) is a medication used for the treatment of adults with anemia (low red blood cells) associated with beta thalassemia or myelodysplastic syndromes.

Facts about luspatercept-aamt for injection

DISEASE INDICATIONS-Lymphoma
Dosage Forms and Strengths: For injection: 25 mg lyophilized powder in a single-dose vial for reconstitution (3) For injection: 75 mg lyophilized powder in a single-dose vial for reconstitution.
MANUFACTURER-Bristol-Myers Squibb
USAGE-Subcutaneous
MEDICINE APPROVED BY-European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “luspatercept-aamt for injection” based on the information you provide.

LYNPARZA (olaparib) tablets

Breast Cancer, Ovarian, Pancreatic, Prostate

LYNPARZA (olaparib) tablets, for oral use Initial U.S. Approval: 2014

It targets specific enzymes within cancer cells and stops the cancer cell from growing. This medicine is used to treat certain kinds of ovarian cancer, breast cancer, pancreatic cancer, and prostate cancer.

Brand Name:	LYNPARZA
Generic Name:	olaparib
Strength:	• Tablets: 150 mg, 100 mg
Manufacturer:	AstraZeneca
Approved By:	EMA, USFDA

Source Details: Patient Information

IPN, New Delhi can facilitate patient to import of “LYNPARZA (olaparib) tablets” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for LYNPARZA (olaparib) tablets price list or cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.

margetuximab-cmkb injection

Breast Cancer

margetuximab-cmkb injection
for intravenous use Initial U.S. approval: 2020

Margenza (margetuximab-cmkb) is a medication used in combination with chemotherapy, to treat adults with metastatic HER2-positive breast cancer after at least two previous rounds of therapy.

Facts about margetuximab-cmkb injection

Disease Indications-Breast Cancer
Manufacturer-MacroGenics
Usage-Intravenous
Medicine Approved By-Food and Drug Administration (FDA)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “margetuximab-cmkb injection” based on the information you provide.

Mavenclad (cladribine)

Neuro, Multiple Myeloma, Multiple Sclerosis

Mavenclad (cladribine)

Mavenclad (cladribine) is a brand-name oral tablet that’s prescribed for relapsing-remitting multiple sclerosis (MS) and active secondary progressive MS. This article covers topics such as side effects, dosage, and how Mavenclad works. Mavenclad belongs to a drug class called purine antimetabolites.

Brand Name:	Mavenclad
Generic Name:	cladribine
Strength:
Manufacturer:
Approved By:	EMA, USFDA

Source Details: Patient Information

IPN, New Delhi can facilitate patient to import of “Mavenclad (cladribine)” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for Mavenclad (cladribine) price list or cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.

Mektovi (Binimetinib) Tablets

Lung Cancer, Skin, Solid Tumors

Brand Name: Mektovi. Generic Name: (Binimetinib). It is used to treat melanoma and non-small cell lung cancer (NSCLC).

Mektovi is used in combination with another medicine, encorafenib , to treat:

melanoma (a skin cancer) that has spread or cannot be removed by surgery;
a type of lung cancer called non-small cell lung cancer (NSCLC). It is used when the cancer is advanced and has the BRAF V600E version of the mutation.

Brand Name:	Mektovi
Generic Name:	Binimetinib
Strength:	• Tablets: 15 mg.
Manufacturer:	Pfizer Inc.
Approved By:	EMA, USFDA

Source Details: Patient Information

IPN, New Delhi can facilitate patient to import of “Mektovi (Binimetinib) Tablets” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for pharma product cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.

« Older Entries

Next Entries »

Contact Info

CORPORATE OFFICE:
Basement-B-5-A, Ajit Singh House Building No.12, Yusuf Sarai, South Delhi,
New Delhi:110016 India.

MOBILE / PHONE NUMBER:
M: +91 9811747774, 9891296838.
P / F: +91-11-26532129 / 26536398

EMAIL ID:
info@indianpharmanetwork.co.in

FAX NUMBER:
+91-11-26532129

Query Form For Medications

Note

We are the facilitator, group of highly qualified healthcare professionals, provide solutions on how to get access of anti cancer medicines not available in India. On the basis of permission in Form 12B (Import permit) from From Ministry of Health, Government of India, IPN, New Delhi procure drugs on behalf of patient.

Disclaimer

“Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in is intended to provide general information about consultancy services offered by IPN and to help users access this information in a user friendly format. Certain information available on the website has been sourced from publicly available sources. While Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in believes such information to be reasonably accurate, Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in has not independently verified any of this information. All information on the IPN website is of general nature and is not a substitute for medical prescription. None of the medicines or products mentioned on the IPN website are manufactured or sold by IPN Pharma Network.

Privacy Policy

Please read the following statement to learn about our information gathering and dissemination practices in relation to our consultancy services (“Services”). Note: Our privacy policy is subject to change at any time without notice. To make sure you are aware of any changes, please review this policy periodically. By visiting the Indian Pharma Network

Health Information

“All information available on the Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in is of general nature and is not a substitute for professional medical advice by a licensed practitioner. Indian Pharma Network (IPN) does not purport to provide any medical or health-related advice, even of general nature and therefore you should not use or consult the Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in for any questions in relation to your health or medical condition.

Shipped Anti-Cancer Medicines.

Indian Pharma Network is registered medical pharmacy for Oncology Products in India. Helps you to access FDA approved Anti-Cancer-Medicines, no matter where you live. Sourcing each medicine for named patient use and overseeing every aspect of the shipping, customs and delivery. We have helped more than 6,000 patients. Send your enquiry to find the What is the cost of Anti Cancer Medicines in Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik, and various other regions in India.

Indian Pharma Network (IPN), New Delhi. India

Indian Pharma Network

60/4 1st Floor, T&T Building, Indian Oil Complex, Yusuf Sarai, Delhi 110016

Mobile / WhatsApp / Phone
M: +91 9811747774, 9891296838.
P: +91-11-26532129 / 26536398

Free Customer Support
info@indianpharmanetwork.co.in
urgent@indianpharmanetwork.co.in

Solid Tumors

Libtayo (cemiplimab)

LITFULO (ritlecitinib) capsules, for oral use Initial U.S. Approval: 2023

loncastuximab tesirine-lpyl for injection for intravenous use Initial U.S. Approval: 2021

Facts about loncastuximab tesirine-lpyl for injection

Access the best support services globally

Lorviqua 25 mg film-coated tablets

Facts about Lorviqua tablets

Access the best support services globally

Zepzelca 4 Mg Intravenous Solution Alkylating Agents

Access the best support services globally

luspatercept-aamt for injection for subcutaneous use Initial U.S. Approval: 2019

Facts about luspatercept-aamt for injection

Access the best support services globally

LYNPARZA (olaparib) tablets, for oral use Initial U.S. Approval: 2014

margetuximab-cmkb injection for intravenous use Initial U.S. approval: 2020

Facts about margetuximab-cmkb injection

Access the best support services globally

Mavenclad (cladribine)

Brand Name: Mektovi. Generic Name: (Binimetinib). It is used to treat melanoma and non-small cell lung cancer (NSCLC).

Contact Info

Query Form For Medications

Note

Disclaimer

Privacy Policy

Health Information

Shipped Anti-Cancer Medicines.

Indian Pharma Network (IPN), New Delhi. India

loncastuximab tesirine-lpyl for injection
for intravenous use Initial U.S. Approval: 2021

Zepzelca 4 Mg Intravenous Solution
Alkylating Agents

luspatercept-aamt for injection
for subcutaneous use Initial U.S. Approval: 2019

margetuximab-cmkb injection
for intravenous use Initial U.S. approval: 2020